Stereotaxis plans to launch the MAGiC cardiac ablation catheter in early 2026, CEO and Chair David Fischel tells MassDevice.

The MAGiC catheter is designed to perform minimally invasive cardiac ablation procedures that treat various forms of ...

Stereotaxis CEO David Fischel says the MAGiC catheter was designed "to overcome the natural limitations of manual pull-wire ...

Chloe Dygert revealed that she recently underwent a procedure to treat heart arrhythmia. The U.S. Olympic medalist confirmed doctors carried out a cardiac ablation to treat supraventricular ...

Deltona, Fla.-based Advanced Heart and Vascular Surgery Center, an affiliate of Cardiovascular Centers of America, has become the first ASC in Florida to launch a complete cardiac ablation service ...

Stereotaxis’ CEO said the company has been “hampered clinically, commercially and strategically” by its prior dependence on a J&J catheter.

CMS has approved electrophysiology ablation procedures for the ASC setting, marking a major advancement for outpatient cardiology and potentially accelerating the specialization of cardiac ASCs.

Untreated or unmanaged, SVT can lead to other possibly fatal heart abnormalities. Patients are advised to practice a cardiac-friendly diet and lifestyle (low sodium, little to no caffeine or alcohol, ...

Stereotaxis has won FDA approval for the MAGiC Magnetic Interventional Ablation Catheter. The device is a robotically ...